Navigation Links
QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
Date:10/12/2010

nus. QIAGEN and Abbott believe that these agreements significantly strengthen the value of their respective automation platforms and will reinforce their leadership in infectious disease testing. QIAGEN's QIAsymphony RGQ system was launched last month with a broad portfolio of assays, including HIV, HBV and HCV tests, and is registered for clinical use in European markets.

"The agreement is a good strategic fit," said QIAGEN's CEO Peer Schatz. "It has the potential to significantly accelerate our dissemination strategy for the QIAsymphony RGQ by expanding our molecular diagnostic menu offering in the United States with important testing options. It also allows us to commercialize previously unused intellectual property around a PCR design for HPV assays by converting it into revenue and by targeting it into a clearly defined sub-segment of the market. And, finally, it enables both parties to address the different market segments for HPV and thereby promises to further drive market adoption of this important testing method in North America."

"We're pleased to provide QIAGEN access to our leading technology, and believe the addition of a PCR-based HPV test to our m2000 menu will benefit many more women who may be infected with the virus and at risk of developing cervical cancer," said Stafford O'Kelly, head of Abbott's molecular diagnostics business.

QIAGEN's portfolio already includes a broad menu of assays including FDA approved assays for HPV (digene HPV) and chlamydia as well as CE-labeled tests for the detection of HIV, HCV, hepatitis B virus (HBV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes-simplex virus (HSV), Influenza, multiple bacteria and respiratory viruses, personalized healthcare assays such as KRAS, EGFR, as well as many other target diseases. In addition, QIAGEN has a broad pipeline of additional and novel assays for its QIAsymphony and QIAensemble platforms for launch in the U.S., Europe and in many other countries
'/>"/>

SOURCE QIAGEN
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
2. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
3. QIAGEN Acquires Exclusive Licence for Key PI3K gene
4. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
5. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
6. Plexus Awarded Development Contract With QIAGEN
7. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
8. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
9. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
10. SciQuest Announces Strategic Alliance with QIAGEN
11. Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014 According to new ... Service Type (Consulting, Integration, Deployment & Support), by ... Model (Public, Private, Others (Hybrid & Community)) - ... and segments the Cloud Professional Services Market into ... of revenues. It also identifies the drivers and ...
(Date:10/22/2014)... 2014 Nuvilex, Inc. (OTCQB: NVLX) – According ... worldwide are living with diabetes, with  that number expected ... global market for diabetes treatments is approximately $500 billion.  ... died from pancreatic cancer.  Pancreatic cancer is the fourth ... the United States , and according ...
(Date:10/20/2014)... October 20, 2014 The report ... Dispensing Systems, Packaging and Labeling Systems, Table-top Counters) ... - Global Forecasts & Trends to 2019” analyzes ... opportunities in North America, Europe, Asia-Pacific, and the ... market tables and 30 figures spread through 300 ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
Breaking Biology Technology:Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... the Supreme Court in eBay Inc. v. Mercexchange LLC, ... should be granted an injunction must be determined under ... injury; (2) inadequacy of remedies at law; (3) balancing ... rejected the Federal Circuit's approach that an injunction should ...
... of the leading Big Pharma companies of 2005. I promised you, at ... products and deals of 2005. , ,Let's get to it: , ... Disease Area Sales ($billions) ... $12.9 +6% 2. Plavix (Bristol-Myers Squibb) ...
... a developer of protein chip technologies, has received ... National Institutes of Health to develop a test that ... estimated 50 million Americans suffer from mild to chronic ... for children and senior citizens. GenTel's protein chips use ...
Cached Biology Technology:Supreme Court decision in eBay case could affect value of patents 2Big Pharma's continued hunger and search for new products 2Big Pharma's continued hunger and search for new products 3Big Pharma's continued hunger and search for new products 4GenTel gets federal grant to develop allergy test 2GenTel gets federal grant to develop allergy test 3
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
(Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
Breaking Biology News(10 mins):New report synthesizes best available science on management of moist mixed-conifer forests 2New perspectives for development of an RSV vaccine 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... Purdue University researchers have found a genetic mutation that allows ... discovery that could reduce the amount of water required for ... conditions. Plants can naturally control the opening and closing ... water. During drought conditions, a plant might close its stomata ...
... study recently published in the journal Biology Letters ... much as bamboo forests. This work, which was ... Chinese Academy of Science, San Diego Zoo Global, China ... Sichuan Forestry Department, could assist conservationists in creating strategic ...
... RIVERSIDE, Calif. Ten researchers at the University of California, ... the Advancement of Science ( AAAS ). Including this year,s ... been recognized with AAAS Fellow distinction is 190. Election ... by their peers. This year AAAS gave this honor to ...
Cached Biology News:Gene helps plants use less water without biomass loss 210 UC Riverside researchers recognized by the American Association for the Advancement of Science 210 UC Riverside researchers recognized by the American Association for the Advancement of Science 3
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Request Info...
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: